Randomized controlled trial of hydrolyzed fish diets in dogs with chronic enteropathy
Journal of Veterinary Internal Medicine · 2023-11-01 · 37 (6) · 2334-2343
DOI: 10.1111/jvim.16844 ↗At a glance
Randomisierte kontrollierte Studie in Journal of Veterinary Internal Medicine, published online on 2023-11-01. Written by Kenneth W Simpson and 5 co-authors. Institution: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA. Major MEDLINE topics: Dog Diseases, Inflammatory Bowel Diseases, Protein-Losing Enteropathies, Fish Products. Cited 21 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Farmina Pet Foods.
Abstract (original language)
Background
The role of diet in the pathogenesis and treatment of chronic enteropathies (CE) in dogs is unresolved.
Objectives
To compare the ability of diets composed of hydrolyzed fish, rice starch, and fish oil without (HF) or with prebiotics, turmeric, and high cobalamin (HF+) against a limited ingredient diet containing mixed nonhydrolyzed antigens and oils (control) to resolve clinical signs and maintain serum cobalamin and folate concentrations in dogs with nonprotein losing CE (non-PLE). To determine the ability of hydrolyzed fish diets to support recovery and remission in dogs with PLE. Animals Thirty-one client-owned dogs with CE: 23 non-PLE, 8 PLE.
Methods
Randomized, blinded, controlled trial. Diets were fed for 2 weeks; responders continued for 12 weeks. Nonresponders were crossed over to another diet for 12 weeks. Response was determined by standardized clinical evaluation with long-term follow-up at 26 weeks. Concurrent medications were allowed in PLE.
Results
Nineteen of 23 (83%; 95% confidence interval [CI], 60%-94%) non-PLE CE responded clinically to their initial diet, with no difference between diets (P > .05). Four nonresponders responded to another diet, with sustained remission of 18/18 (100%; 95%CI, 78%-100%) at 26 weeks. Serum cobalamin concentration was increased (P < .05) and maintained by diet. Serum folate concentration decreased posttreatment (P < .05) but was restored by dietary supplementation. Hydrolyzed fish diets supported weight gain, serum albumin concentration, and recovery (P < .05) in dogs with PLE. Conclusions and Clinical Importance Changing diet, independent of antigen restriction or supplemental ingredients, induced long-term remission in dogs with non-PLE CE. Serum cobalamin and folate concentrations were maintained by diet. Hydrolyzed fish diets supported clinical recovery and remission in PLE.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
ORCID profiles: Kenneth W Simpson, Meredith L Miller, John P Loftus, Mark Rishniw
Funding
- Farmina Pet Foods
Cite
APA
Simpson, K. W., Miller, M. L., Loftus, J. P., Rishniw, M., Frederick, C. E., & Wakshlag, J. J. (2023). Randomized controlled trial of hydrolyzed fish diets in dogs with chronic enteropathy. Journal of Veterinary Internal Medicine, 37(6), 2334-2343. https://doi.org/10.1111/jvim.16844
Vancouver
Simpson KW, Miller ML, Loftus JP, Rishniw M, Frederick CE, Wakshlag JJ. Randomized controlled trial of hydrolyzed fish diets in dogs with chronic enteropathy. Journal of Veterinary Internal Medicine. 2023;37(6):2334-2343. doi:10.1111/jvim.16844
BibTeX
@article{Simpson2023,
author = {Simpson, Kenneth W and Miller, Meredith L and Loftus, John P and Rishniw, Mark and Frederick, Carol E and Wakshlag, Joseph J},
title = {Randomized controlled trial of hydrolyzed fish diets in dogs with chronic enteropathy},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
volume = {37},
number = {6},
pages = {2334--2343},
doi = {10.1111/jvim.16844}
}
EUVIMED